134058 - Understanding the renewed National Cervical Screening Program
- : Online
This activity is designed to familiarise general practitioners (GPs) with changes to the National Cervical Screening Program (NCSP) that took effect from December 2017. It is important that GPs are aware of these changes as they are extensive and apply to a large proportion of the average GP patient base.
It focuses on the main changes that will affect how you collect cervical samples, request cervical screening tests and follow up screen-detected abnormalities in general practice.
This activity has been developed by the Royal Australian College of General Practitioners.
Tempo activities are designed as quick, 30 minute activities (when both the Overview and Interactive activity are completed) but recognise the additional effort GPs undertake when utilising the supplemental resources provided. Hence, this activity has been approved by the RACGP QI&CPD Program for Category 2 points in the 2017-2019 triennium.
Relevance to General Practice
Australian rates of cervical cancer incidence and death are among the lowest in the world. This is largely attributed to the successful introduction of:
cervical screening through the NCSP, established in 1991 to detect and treat abnormalities while they are in the precancerous stage, before any possible progression to cervical cancer
vaccination against human papilloma virus (HPV), through the National HPV Vaccination Program, to prevent women being infected with oncogenic HPV types 16 and 18.
From December 2017 changes to the cervical screening program were implemented. It is important that GPs are aware of these changes as that are extensive and apply to a large proportion of the average GP patient base (ie all women, approximate 18-70 years of age, who would have previously been in the age group for Pap tests).
- outline the changes to performing routine cervical screening introduced in December 2017
- describe the process for determining appropriate management of screen detected abnormalities
- explain variations in approach to screening for specific population groups.